View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 11, 2020

Blink Science to launch biosensor device for Covid-19 detection

Biotechnology and medical device company Blink Science is set to launch a new handheld biosensor device for the immediate detection of Covid-19 and other disease biomarkers in saliva.

Biotechnology and medical device company Blink Science is set to launch a new handheld biosensor device for the immediate detection of Covid-19 and other disease biomarkers in saliva.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Called blinkTEST, the new device is designed to offer health reports that can be analysed immediately to diagnose acute and chronic conditions.

It offers instantaneous results without requiring costly genetic testing.

Most of the point-of-care (POC) testing devices currently available, or that have received emergency use authorisation (EUA), offer tests in well over 20-30 minutes, the company noted.

Blink Science ’s device uses a patented electronic technology that will detect a range of biomarkers.

The blinkTEST biosensor can read the electrical charges between antibodies and an easy-to-use test strip.

Blink Science CEO and president Eric Doherty said: “What we are bringing to market is revolutionary. This device will be able to provide the fastest test not only for Covid-19 but also for a number of other viruses and specific disease states.”

Currently, Blink Science is looking to develop strategic licensing and manufacturing relationships to accelerate to the market launch of the new device.

The company also plans to partner with corporate and investment companies for the rapid development of the product.

Blink Science is a SpinUp Campus company, which focuses on connecting university scientists with investors to transform significant research into viable businesses.

SpinUp Campus CEO and founder Billy Meadow said: “I am tremendously excited to have a stellar team led by Eric Doherty to commercialise this amazing molecular diagnostic innovation coming out of the University of Florida. This device will change the global diagnostics industry and save lives.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network